Amendment to Quarterly Report (Form 10-Q/A)

Cytta Corp (referred to herein as the "Company," "Cytta" we," "us," or "our") is filing this Amendment No. 1 on Form 10-Q (this "Amendment No. 1") to amend our Quarterly Report on Form 10-Q for the three ended December 31, 2024, initially filed with the Securities and Exchange Commission (the "SEC") on February 14, 2025 ("Original 10-Q").

Background of Restatement

The purpose of this Amendment No. 1 is to restate amounts included in the Company's previously issued financial statements as of and for the three months ended December 31, 2024, to correct misstatements for certain assumptions used to report accounts receivable, deferred revenue and revenue recognized.

The restatement had no impact on total net cash flows from operating, investing or financing activities.

For additional information related to the restatement, see Note 13, "Restatement of Previously Issued Unaudited Interim Condensed Financial Statements " of the condensed consolidated financial statements.

Additionally,

Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in this Amendment No. 1 on Form 10-Q/A is being amended to reflect the effect of the restatement described above.

The Company has attached to this Form 10-Q/A updated certifications executed as of the date of this Amendment No. 1 by the Principal Executive Officer and Principal Financial Officer as required by Sections 302 and 906 of the Sarbane Oxley Act of 2002. These updated certifications are attached as Exhibits 31.1, 31.2 and 32.1 to this Amendment.

CYTTA CORP.

INDEX